Immunoglobulin (Ig) product is a precious and high cost resource requiring careful management. Ig may only be supplied to eligible patients authorised under the Criteria for the clinical use of immunoglobulin in Australia1 (Criteria).
The purpose of this Module is to assist health providers in meeting the requirements of the Ig Governance National Policy2 (National Policy) by:
- describing how to establish and manage stock levels
- outlining the Ig product ordering models
- identifying different methods to determine ordering requirements/trigger
- providing recommendations for good practice
This guidance should be read in conjunction with the basic overarching inventory management principles provided in Managing Blood and Blood Product Inventory: Guidelines for Australian Health Providers.3